Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy

• Clara Theunis ,

  Contributed equally to this work with: Clara Theunis, Natalia Crespo-Biel

  Affiliation Experimental Genetics Group, Department Human Genetics, KU Leuven, Leuven, Belgium

  ⨯
• Natalia Crespo-Biel ,

  Contributed equally to this work with: Clara Theunis, Natalia Crespo-Biel

  Affiliation Experimental Genetics Group, Department Human Genetics, KU Leuven, Leuven, Belgium

  ⨯
• Valérie Gafner,

  Affiliation ACImmune, Lausanne, Switzerland

  ⨯
• Maria Pihlgren,

  Affiliation ACImmune, Lausanne, Switzerland

  ⨯
• María Pilar López-Deber,

  Affiliation ACImmune, Lausanne, Switzerland

  ⨯
• Pedro Reis,

  Affiliation ACImmune, Lausanne, Switzerland

  ⨯
• David T. Hickman,

  Affiliation ACImmune, Lausanne, Switzerland

  ⨯
• Oskar Adolfsson,

  Affiliation ACImmune, Lausanne, Switzerland

  ⨯
• Nathalie Chuard,

  Affiliation ACImmune, Lausanne, Switzerland

  ⨯
• Dorin Mlaki Ndao,

  Affiliation ACImmune, Lausanne, Switzerland

  ⨯
• Peter Borghgraef,

  Affiliation Experimental Genetics Group, Department Human Genetics, KU Leuven, Leuven, Belgium

  ⨯
• Herman Devijver,

  Affiliation Experimental Genetics Group, Department Human Genetics, KU Leuven, Leuven, Belgium

  ⨯
• Fred Van Leuven ,

  * E-mail: fred.vanleuven@med.kuleuven.be

  Affiliation Experimental Genetics Group, Department Human Genetics, KU Leuven, Leuven, Belgium

  ⨯
• Andrea Pfeifer,

  Affiliation ACImmune, Lausanne, Switzerland

  ⨯
• Andreas Muhs

  Affiliation ACImmune, Lausanne, Switzerland

  ⨯